What every intensivist should know about Tocilizumab

被引：10

作者：

Hofmaenner, Daniel Andrea ^{[1
]}

Wendel Garcia, Pedro David ^{[1
]}

Ganter, Christoph Camille ^{[1
]}

Brugger, Silvio D. ^{[2
]}

Buehler, Philipp Karl ^{[1
]}

David, Sascha ^{[1
]}

机构：

[1] Univ Zurich, Univ Zurich Hosp, Inst Intens Care Med, Ramistrasse 100, CH-8091 Zurich, Switzerland

[2] Univ Zurich, Univ Zurich Hosp, Dept Infect Dis & Hosp Epidemiol, Zurich, Switzerland

来源：

CRITICAL CARE | 2021年 / 25卷 / 01期

关键词：

D O I：

10.1186/s13054-021-03696-1

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页数：3

共 6 条

[1] Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management [J].

Brudno, Jennifer N. ;

Kochenderfer, James N. .

BLOOD REVIEWS, 2019, 34 :45-55

[2]

Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI [10.1056/NEJMc2108482, 10.1056/NEJMoa2100433]

[3]

Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]

[4] Appropriate use of tocilizumab in COVID-19 infection [J].

Keske, Siran ;

Tekin, Suda ;

Sait, Bilgin ;

Irkoren, Pelin ;

Kapmaz, Mahir ;

Cimen, Cansu ;

Ugur, Semra ;

Celebi, Irfan ;

Bakir, Veli Oguzalp ;

Palaoglu, Erhan ;

Senturk, Evren ;

Caglayan, Benan ;

Cakar, Nahit ;

Tabak, Levent ;

Ergonul, Onder .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 :338-343

[5] Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement [J].

Paladugu, Susmita ;

Donato, Anthony A. .

ANNALS OF INTERNAL MEDICINE, 2020, 173 (02) :JC5-JC5

[6] Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study [J].

Pawar, Ajinkya ;

Desai, Rishi J. ;

Solomon, Daniel H. ;

Ortiz, Adrian J. Santiago ;

Gale, Sara ;

Bao, Min ;

Sarsour, Khaled ;

Schneeweiss, Sebastian ;

Kim, Seoyoung C. .

ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04) :456-464

← 1 →